Andere talen Viveve Medical, Inc.

Aandelen

VIVE

US92852W5013

Beurs gesloten - OTC Markets Andere beurzen 15:31:17 17-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0002 ^USD	0,00%		-33,33%	0,00%

2023	InMode Ltd. (NasdaqGS:INMD) heeft de intellectuele eigendommen van Viveve Medical Inc. overgenomen.	CI
2023	Sectorupdate: Aandelen in de gezondheidszorg eindigen dicht bij de dieptepunten van de dag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	25-07-23
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	23-01-23
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	18-01-23
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index	18-01-23
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	17-01-23
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	17-01-23
Top Midday Decliners	17-01-23
Sector Update: Health Care	17-01-23
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	17-01-23
Sector Update: Health Care	17-01-23
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	17-01-23
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	17-01-23
Top Premarket Decliners	17-01-23
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	17-01-23
Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K	17-01-23
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	17-01-23
VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	17-01-23
Viveve Medical to Seek Strategic Alternatives	17-01-23
VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	15-12-22
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	15-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Viveve Medical, Inc.

Aandelen

VIVE

US92852W5013

Andere talen

Filters